Can I Have Surgery if I Have a Herpes Outbreak?

Most surgeries can proceed even if you have a herpes outbreak, but the answer hinges on what kind of surgery, where the outbreak is, and how urgent the procedure is. Elective surgeries near the site of active lesions are the most likely to be postponed, while urgent or emergency procedures generally go ahead with antiviral medications added to the plan. The concern is less about anesthesia safety or operating-room logistics and more about what the virus does to healing tissue and the risk of spreading infection to a fresh surgical wound.

Why an Active Outbreak Matters for Surgery

During an active herpes outbreak, the virus is replicating and shedding from the sores. When a surgeon cuts into or near tissue where the virus is active, two problems arise. First, the virus can spread from the outbreak site to the fresh wound, potentially causing a herpes infection at the surgical site. A case report in the orthopedic literature described exactly this: herpes simplex virus caused a superficial wound infection after a total hip replacement, illustrating that the virus can reach surgical wounds even at sites seemingly unrelated to the original outbreak.¹ Second, active HSV infection interferes with wound repair. Animal research has shown that acute HSV-1 infection delays healing of surgical wounds by roughly three days, and antiviral treatment with acyclovir helped reduce inflammation and improve the healing timeline.²

These complications are manageable in most cases, but they add risk that your surgeon wants to minimize when possible. The calculus is straightforward: if the surgery can safely wait a week or two for the outbreak to resolve, most surgeons will wait. If it cannot wait, antiviral drugs are prescribed and the surgery proceeds.

Elective Procedures Near the Outbreak Are Most Likely to Be Postponed

The surgeries most commonly delayed by an active outbreak are elective cosmetic procedures on the face and mouth, for a practical reason. Procedures like laser skin resurfacing, chemical peels, dermabrasion, and injectable treatments create controlled trauma to the skin, and that trauma can provoke the virus to reactivate even in someone without an active outbreak. If someone already has active sores, the risk of viral spread into the treated area jumps. CO2 laser resurfacing in particular has been linked to herpes reactivation, which can cause delayed healing and scarring.³

A guideline on managing herpes simplex in the context of cosmetic procedures noted that reactivation following cosmetic interventions is considered rare, though reliable incidence data do not exist. The authors emphasized patient screening and prophylactic antiviral use as the main strategies for reducing this risk.⁴ In practice, most cosmetic surgeons and dermatologists will ask you to reschedule if you arrive on procedure day with visible cold sores or genital lesions, especially for anything involving the face, lips, or perioral area.

The same logic applies to rhinoplasty and similar facial surgeries. A case report following open septorhinoplasty described a patient who developed redness, swelling, and then itchy, painful blisters around the surgical site within days of the procedure. The team initially suspected a bacterial infection before a dermatologist confirmed HSV reactivation. Valacyclovir and topical acyclovir cream resolved the symptoms within three days.⁵ That case underscores why many facial surgeons prefer to operate when no active outbreak is present.

Antiviral Medication Is the Workhorse of Prevention

Whether or not you have an active outbreak at the time of surgery, antiviral drugs are the standard tool for preventing herpes-related complications. The three drugs you will hear about are acyclovir, valacyclovir, and famciclovir. They work by blocking viral replication, and when taken before and after a procedure, they substantially reduce the odds of the virus flaring at the surgical site.

In a clinical trial of valacyclovir given before facial laser resurfacing, the drug was completely effective at preventing HSV reactivation with no adverse effects reported in either dosing regimen tested.⁶ Famciclovir has also been studied in the same context. Researchers found that twice-daily famciclovir at either 250 mg or 500 mg effectively prevented HSV recurrence in patients undergoing cutaneous laser resurfacing, with the higher dose recommended for patients with a strong history of outbreaks.⁷

In most protocols, you begin the antiviral a day or two before surgery and continue it for a week or more afterward. If you have an active outbreak at the time of a non-elective surgery, your surgeon will typically start antivirals immediately rather than wait. This approach does not eliminate all risk, but it reduces it substantially. If you already take a daily suppressive antiviral for frequent outbreaks, your surgeon may simply keep you on that regimen or adjust the dose.

Cesarean Delivery and Genital Herpes

The intersection of herpes and surgery gets the most attention in obstetrics, because the stakes involve a newborn. The concern is neonatal herpes, a rare but potentially devastating infection a baby can acquire while passing through a birth canal with active genital lesions.

The standard recommendation is that a woman experiencing her first clinical episode of genital herpes at the time of delivery should have a cesarean section. That first episode carries the highest risk of transmission to the baby because the mother has not yet developed antibodies that provide some passive protection. For women with a history of recurrent genital herpes who happen to have a recurrence at delivery, the picture is more nuanced. A cost-effectiveness analysis in JAMA noted that cesarean delivery for women with recurrent lesions at delivery leads to high maternal morbidity and mortality at substantial financial cost, and stressed the need for alternative management strategies.⁸

In practice, many obstetricians still perform cesarean deliveries when recurrent lesions are visible at the time of labor, but antiviral suppressive therapy in the final weeks of pregnancy has become a common strategy to reduce the likelihood of an outbreak being present at all. If you have a history of genital herpes and are pregnant, the conversation about antivirals typically starts well before your due date.

Is Anesthesia Safe During an Outbreak?

A concern that comes up frequently, especially for people with genital herpes, is whether it is safe to receive spinal or epidural anesthesia during an active outbreak. The worry is that placing a needle into the spinal space could theoretically introduce the virus into the central nervous system. This fear is understandable but not well supported by the evidence for recurrent infections.

A retrospective review of 89 women with active recurrent genital herpes who received epidural anesthesia for cesarean section found no adverse outcomes related to either the anesthetic or the virus. The authors concluded that the risk was small and did not contraindicate epidural use in patients with recurrent infection.⁹ A larger study looking at 169 patients with HSV-2 infections who received different anesthesia types during cesarean delivery, including general, spinal, and epidural, echoed that finding. Among patients with secondary (recurrent) infections, no one had septic or neurologic complications related to the anesthetic. Both spinal and epidural anesthesia appeared to be safe alternatives.¹⁰ A case report of a patient with both active herpes labialis and AIDS-related illness who underwent urgent cesarean section under spinal anesthesia also described no intraoperative problems.¹¹

The distinction between a first episode and a recurrence matters here. A primary (first-ever) herpes infection involves much higher viral loads and no existing immune response, so anesthesiologists may be more cautious. For recurrent outbreaks, the evidence points toward regional anesthesia being a reasonable choice. Still, your anesthesiologist will want to know about any active lesions so they can make a fully informed decision, and they may choose a needle-insertion site well away from any sores.

Surgery Itself Can Trigger a Herpes Reactivation

Even if you have no outbreak when you go into surgery, the stress and tissue trauma of the procedure itself can wake up the dormant virus. This is not limited to procedures near the face or genitals. Surgical stress, general anesthesia, and postoperative steroid medications can all serve as triggers.

One particularly striking finding involves intubation during general anesthesia. A study of patients who had oral endotracheal tubes in place found that roughly half of those intubated for more than 48 hours during the first postoperative week developed reactivation of herpes simplex virus, with only half of those positive cases being clinically recognizable.¹² That means a large proportion of reactivations go unnoticed because they do not produce obvious sores. For most people this silent reactivation causes no problems, but in immunocompromised patients or during surgeries where oral healing matters, it becomes clinically relevant.

Pediatric cases also appear in the literature. A report from the American Epilepsy Society described a 12-year-old who developed HSV reactivation four days after epilepsy surgery. The child developed seizures, meningeal signs, confusion, lethargy, and high fever. Cerebrospinal fluid tested positive for HSV, but the patient recovered after acyclovir treatment was started, with seizures stopping within 48 hours and confusion resolving shortly after.¹³ Cases like this are uncommon, but they illustrate why surgeons and anesthesiologists ask about herpes history during pre-surgical evaluations.

Eye Surgery Requires Extra Caution

If you have a history of herpes keratitis, the form of herpes that affects the cornea, eye surgery carries its own set of considerations. Several types of eye procedures disrupt the corneal nerve plexus, including cataract surgery, corneal transplants, corneal cross-linking, and laser vision correction. That nerve disruption, combined with the steroid eye drops routinely prescribed after surgery, can trigger herpes reactivation in the eye.¹⁴

Evidence is strongest for oral antiviral prophylaxis in patients undergoing corneal transplant (penetrating keratoplasty) who have a history of herpes keratitis. For other types of eye surgery, the evidence is less definitive, but a period of disease quiescence before the procedure and oral antiviral prophylaxis around the surgical date are still widely recommended.¹⁵ If you have had herpes in or around your eye, your ophthalmologist needs to know before any procedure, even one that seems routine. The reactivation risk is real enough that it shapes how and when the surgery is scheduled.

Immunocompromised Patients and Chronic Herpes

The conversation about surgery and herpes changes significantly for people with weakened immune systems, particularly those with HIV or those on immunosuppressive medications after organ transplants. In these patients, herpes outbreaks can be more severe, more widespread, and less responsive to standard antiviral doses.

A subset of immunocompromised patients, particularly those with HIV, do not respond to typical antiviral therapy and develop chronic, severe herpes infections. These can take unusual forms, including large, tumor-like growths in the anogenital area that can be mistaken for cancer. In such cases, surgical excision of the herpes lesions themselves has been used as a treatment when antiviral medications have failed.¹⁶ The majority of these patients had CD4 counts below 500 cells per cubic millimeter and atypical presentations.

For immunocompromised individuals facing any kind of surgery, the threshold for starting antiviral prophylaxis is lower and the duration of treatment is often longer. Surgeons are more cautious about operating during an active outbreak in these patients because the body’s compromised ability to contain the virus raises the risk of complications at the surgical site and beyond. If you are immunocompromised and have a herpes history, this is a detail your entire surgical team needs to be aware of well in advance.

What to Tell Your Surgeon

The most practical thing you can do is be upfront about your herpes history during your pre-surgical consultation, not just if you happen to have an outbreak on the day of surgery. Many people feel embarrassed about disclosing a herpes diagnosis, but surgeons and anesthesiologists are not making moral judgments. They are calculating risk. Knowing your history lets them prescribe prophylactic antivirals, choose anesthesia methods thoughtfully, and schedule elective procedures during outbreak-free windows.

If an outbreak appears between your consultation and your surgery date, call the surgeon’s office rather than just showing up and hoping no one notices. For most elective procedures, a short delay is no big deal and spares you the added healing complications. For time-sensitive procedures, the team can start you on antivirals and adjust the plan. The scenario to avoid is an undisclosed outbreak that leads to a postoperative complication nobody was prepared for, because herpes-related wound issues are much easier to prevent than to treat after the fact.

You should also know that a herpes diagnosis, even one with frequent outbreaks, does not make you ineligible for surgery. It means you have an extra variable that requires a small amount of planning. Millions of surgical procedures are performed every year on people who carry herpes simplex virus, and the vast majority go smoothly with appropriate precautions in place.